Skip to main content

Find Clinical Trials

Home
Conditions
Invasive Group B Streptococcus (GBS) Disease

Clinical trial condition

Invasive Group B Streptococcus (GBS) Disease

Explore clinical trials studying Invasive Group B Streptococcus (GBS) Disease. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Invasive Group B Streptococcus (GBS) Disease trial results

Completed

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age

NCT00645346

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +14 more
Locations: Institute for Pharmacokinetic and Analytical Studies I.P.A.S. Ligornetto, Switzerland

View Trial Details

Completed

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age

NCT00657683

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +14 more
Locations: Institute for Pharmacokinetic and Analytical Studies, I.P.A.S. S.A. Ligornetto, Switzerland

View Trial Details